Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
ARNO THERAPEUTICS, INC. | ARNI | OTC Markets | 3,500 | 0.0003 USD | Stock |
News (246)
Companies (1)
Arno Therapeutics, Inc. is an early-stage company focused on developing products for the treatment of cancer and other life threatening diseases. The Company's product development pipeline includes Onapristone, AR-42, and AR-12 and analogs. Onapristone is ...
Insiders
Dr. Arno Antlitz is a Chief Financial Officer at AUDI AG and a Chairman -Supervisory Board at VOLKSWAGEN FINANCIAL SERVICES AG. Dr. Antlitz was previously employed as an Associate Principal by Mckinsey & Co., Inc. (Germany). He received his doctorate degree from WHU-Otto Beisheim School of Management.
Chris Antlitz is a Principal Analyst at Technology Business Research, Inc. He has been in this position since 2008.
He completed his undergraduate degree at the University of New Hampshire.
Arno Lammeretz worked as the Head of Strategic Fund Relations at APG Asset Management NV from 2013 to 2015.
Arno Pätzold is currently working as Co-Managing Director at ARTHOS Corporate Finance GmbH.
Previously, he worked as Chief Development Officer at AUGUSTA Technologie AG from 2010 to 2012.
He completed his undergraduate degree from Technische Universität Darmstadt.
Arno Groeneveld currently works as a Financial Controller at Bron Gascare BV.
No results for this search
- Stock Market
- Advanced search
- Arno Antlitz